ABVC BioPharma, Inc. (ABVC) vs Polyrizon Ltd. (PLRZ)

ABVC BioPharma, Inc. and Polyrizon Ltd. are both Biotechnology companies. ABVC BioPharma, Inc. and Polyrizon Ltd. are of similar size ($24.9M and $23.7M). Across the 7 metrics below, Polyrizon Ltd. leads on 6 and ABVC BioPharma, Inc. on 1.

Valuation

Metric ABVC PLRZ Biotechnology median
P/E n/m — 8.50
P/S 18.38 — 9.71
P/B 1.95 n/m 2.13
Price to free cash flow n/m n/m 20.82
EV/EBITDA n/m n/m 0.64
EV/Sales 19.64 n/m 9.21
Earnings yield (36.91%) — (33.15%)
Free cash flow yield (11.33%) 0.00% (25.50%)

Profitability

Metric ABVC PLRZ Biotechnology median
Gross margin 99.97% — 65.16%
Operating margin 0.00% — 0.00%
Net margin 0.00% — 0.00%
Free cash flow margin 0.00% 0.00% 0.00%
Return on equity (65.32%) 0.00% (56.36%)
Return on assets (39.88%) 0.00% (48.04%)
Return on invested capital (33.45%) 0.00% 0.00%

Growth

Metric ABVC PLRZ Biotechnology median
Revenue growth (TTM) 5,035.43% — 6.02%
EPS growth (last fiscal year) 7.14% 99.37% 30.26%
Revenue growth, 5-year CAGR (6.20%) — 9.41%
Net income growth, 5-year CAGR 0.00% — 0.00%

Health

Metric ABVC PLRZ Biotechnology median
Debt to equity 0.00 0.00 0.00
Current ratio 0.07 36.37 4.72
Net debt to EBITDA 0.21 2.11 0.96

Dividend

Metric ABVC PLRZ Biotechnology median
Dividend yield — — 0.09%
Payout ratio — — —

Size

Metric ABVC PLRZ Biotechnology median
Market cap 24.89m 23.74m 135.18m

Compare with another peer

Any metric, up to five companies and an Excel export Powerpack